Frontier Investment Management’s Novo Nordisk NVO Stock Holding History

Frontier Investment Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$209K	Buy	+6,396	New	+$204K	0.01%	250

Other funds holding NVO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

EHC

Everett Harris & Co Los Angeles, California $7.77B AUM 9.43% 1-Year Est. Return

Frontier Investment Management's NVO Position: Q2 2020 in Review

Frontier Investment Management opened a new position in Novo Nordisk (NVO) in Q2 2020: 6,396 shares worth $209K. The stake represents 0.01% of the portfolio and ranks #250 among its holdings.

660 funds tracked by Wall St. Rank hold NVO as of Q2 2020.

Frontier Investment Management held 6,396 shares of Novo Nordisk worth $209K as of Q2 2020.
Novo Nordisk was a new Frontier Investment Management position in Q2 2020.
Novo Nordisk made up 0.01% of Frontier Investment Management's portfolio in Q2 2020, its #250 holding.
660 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2020.

Based on Frontier Investment Management's 13F filing for Q2 2020, filed 11 Aug 2020.